NCT07035873 is a NA clinical trial of Remote Programming in Cochlear Implant Listeners, sponsored by Nationwide Children's Hospital.

Who is sponsoring NCT07035873?

NCT07035873 is sponsored by Nationwide Children's Hospital.

What drugs are being tested in NCT07035873?

Interventions in NCT07035873: Remote Programming, Remote Speech Perception.

What condition does NCT07035873 study?

NCT07035873 studies Cochlear Implant Listeners.

Is NCT07035873 still recruiting?

NCT07035873 is currently recruiting now. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07035873

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pediatric Cochlear Implant Remote Programming and Assessment

Recruiting now NA Last updated 13 April 2026

What this trial tests

NA trial testing Remote Programming in Cochlear Implant Listeners in 15 participants. Currently enrolling.

Timeline

15 January 2025

Primary endpoint
15 January 2027

31 March 2027

Quick facts

Lead sponsor	Nationwide Children's Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	15 January 2025
Primary completion	15 January 2027
Estimated completion	31 March 2027
Sites	1 location across United States

Drugs / interventions tested

Remote Programming
Remote Speech Perception

Conditions studied

Cochlear Implant Listeners — all drugs for Cochlear Implant Listeners →

Sponsor

Nationwide Children's Hospital

Who can join

Adults 13 to 20, any sex, with Cochlear Implant Listeners. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measures via iOS mobile application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Remote Programming

Trials testing the same drug.

NCT05193825 — Evaluation of Remote DBS Programming. · NA · completed

Other Nationwide Children's Hospital trials

Trials by the same sponsor.

NCT07435792 — TetraGraph to Evaluate Onset and Recovery Times of Rocuronium · NA · not yet recruiting
NCT07026942 — Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML · Phase 1, PHASE2 · not yet recruiting
NCT06795126 — Little NIRVANA for Pediatric Pain and Anxiety · NA · enrolling by invitation
NCT06854991 — Healthy Children and Virtual Reality Mediation of Simulated Pain · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07035873 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nationwide Children's Hospital
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07035873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing